Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$886M |
| 2 |
Chevron
CVX
|
+$595M |
| 3 |
Union Pacific
UNP
|
+$360M |
| 4 |
Baxter International
BAX
|
+$276M |
| 5 |
Xcel Energy
XEL
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$520M |
| 2 |
NXP Semiconductors
NXPI
|
+$248M |
| 3 |
Oracle
ORCL
|
+$242M |
| 4 |
Amgen
AMGN
|
+$197M |
| 5 |
Eli Lilly
LLY
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.12% |
| 2 | Technology | 7.86% |
| 3 | Healthcare | 6.8% |
| 4 | Industrials | 5.01% |
| 5 | Consumer Discretionary | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
4626
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $669K | ﹤0.01% |
1,555,182
-1,125,918
| -42% | -$1.11M |
|
4627
Century Therapeutics
IPSC
$372M
| $668K | ﹤0.01% |
67,513
+6,946
| +11% | +$73.2K |
|
4628
Arthur J. Gallagher & Co
AJG
$62.9B
| $667K | ﹤0.01% |
3,898
-44,202
| -92% | -$7.85M |
|
4629
SOPHiA GENETICS
SOPH
$548M
| $667K | ﹤0.01% |
253,657
+226,519
| +835% | +$794K |
|
|
LICY
4630
DELISTED
Li-Cycle Holdings Corp.
LICY
| $667K | ﹤0.01% |
15,678
+11,562
| +281% | +$629K |
|
4631
Iris Energy
IREN
$14.8B
| $665K | ﹤0.01% |
161,124
+59,752
| +59% | +$258K |
|
|
FTII
4632
DELISTED
FutureTech II Acquisition Corp. Class A Common Stock
FTII
| $664K | ﹤0.01% |
66,010
| – | – |
|
|
AVID
4633
DELISTED
Avid Technology Inc
AVID
| $663K | ﹤0.01% |
28,499
-117,413
| -80% | -$3.06M |
|
|
HOUS
4634
DELISTED
Anywhere Real Estate
HOUS
| $662K | ﹤0.01% |
+81,667
| New | +$836K |
|
4635
SAP
SAP
$224B
| $662K | ﹤0.01% |
8,148
-256,832
| -97% | -$22.7M |
|
4636
VTEX
VTEX
$759M
| $661K | ﹤0.01% |
+178,619
| New | +$668K |
|
|
HARP
4637
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $661K | ﹤0.01% |
68,117
+10,125
| +17% | +$189K |
|
|
FOCL
4638
EDAP TMS S.A.
FOCL
$237M
| $660K | ﹤0.01% |
+80,052
| New | +$609K |
|
4639
J. Jill
JILL
$284M
| $660K | ﹤0.01% |
+39,715
| New | +$666K |
|
|
NFBK
4640
DELISTED
Northfield Bancorp
NFBK
| $659K | ﹤0.01% |
46,074
-2,601
| -5% | -$37.6K |
|
4641
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
| $659K | ﹤0.01% |
+13,682
| New | +$684K |
|
|
KIIIU
4642
DELISTED
Kismet Acquisition Three Corp. Unit
KIIIU
| $659K | ﹤0.01% |
66,602
-2,293
| -3% | -$22.6K |
|
4643
Allegiant Air
ALGT
$2.88B
| $658K | ﹤0.01% |
+9,017
| New | +$932K |
|
4644
iShares MSCI USA Value Factor ETF
VLUE
$9.47B
| $658K | ﹤0.01% |
+8,037
| New | +$745K |
|
4645
CALL
Cboe Global Markets
CBOE
$30.2B
| $657K | ﹤0.01% |
+5,600
| New | +$674K |
|
4646
Pegasystems
PEGA
$5.2B
| $657K | ﹤0.01% |
40,874
-1,095,554
| -96% | -$22.3M |
|
4647
StealthGas
GASS
$321M
| $654K | ﹤0.01% |
255,477
-144,582
| -36% | -$398K |
|
4648
CALL
Acumen Pharmaceuticals
ABOS
$159M
| $652K | ﹤0.01% |
+65,000
| New | +$373K |
|
4649
NatWest
NWG
$76.6B
| $651K | ﹤0.01% |
130,414
-156,512
| -55% | -$964K |
|
4650
CALL
Revolve Group
RVLV
$1.87B
| $651K | ﹤0.01% |
+30,000
| New | +$789K |
|
Similar funds
Millennium Management's Q3 2022 Portfolio in Review
As of Q3 2022, Millennium Management held 7,917 positions worth $169B, up 4.9% from $161B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $14.7B of net new capital in Q3 2022, opening 1,007 new positions and adding to 2,598 existing holdings. Its largest new stake was Rockwell Automation: 953,525 shares worth $205M.
By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 7.6% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $520M trimmed.
- Millennium Management's largest Q3 2022 buy was Rockwell Automation: 953,525 shares worth $205M.
- Millennium Management added most to Duke Realty Corp. in Q3 2022, an estimated $886M increase.
- Millennium Management's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $520M.
- Millennium Management fully exited Coherent Inc in Q3 2022, selling an estimated $114M.
- Millennium Management's ten largest holdings make up 23% of its $169B portfolio in Q3 2022.
- Millennium Management opened 1,007 new positions and closed 906 in Q3 2022.
- Millennium Management's portfolio value rose 4.9% quarter-over-quarter to $169B.
Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.